Vasopressin receptor 1A

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

(Redirected from V1A receptor)

Vasopressin Receptor 1A' (V1AR), also known as the arginine vasopressin receptor 1A, is a protein that in humans is encoded by the AVPR1A gene. It is a type of receptor for arginine vasopressin, a small peptide hormone that regulates the body's retention of water. The V1AR is a G protein-coupled receptor (GPCR) that plays a critical role in the regulation of vasoconstriction, blood pressure, and kidney function.

Function[edit | edit source]

The V1A receptor is primarily found in the vascular smooth muscle and myocardium, where it mediates the contraction of smooth muscle cells, leading to an increase in blood pressure. It is also present in the brain, where it is involved in a variety of central nervous system functions, including social behavior, pair bonding, and stress response. Activation of the V1A receptor by arginine vasopressin leads to a series of intracellular events involving the activation of phospholipase C and the increase in intracellular calcium levels.

Clinical Significance[edit | edit source]

Alterations in V1A receptor function have been implicated in several diseases, including heart failure, chronic kidney disease, and psychiatric disorders such as autism spectrum disorder and depression. Drugs that act as antagonists to the V1A receptor, known as vaptans, are being explored for the treatment of conditions like hyponatremia and heart failure, by blocking the effects of arginine vasopressin and thus promoting water excretion without loss of electrolytes.

Genetics[edit | edit source]

The AVPR1A gene is located on the short arm of chromosome 12 (12q14-15) and consists of three exons and two introns. Genetic variations in AVPR1A have been studied in relation to social behavior, with some alleles being associated with increased social communication and others with more solitary behaviors. This has led to the hypothesis that the V1A receptor may play a role in the evolutionary basis of social behaviors in humans and other mammals.

Pharmacology[edit | edit source]

Pharmacologically, the V1A receptor is a target for the development of drugs that can modulate vasopressin's effects in the body. Antagonists of the V1A receptor, such as conivaptan and tolvaptan, are used clinically to treat diseases related to water retention and heart failure. These drugs work by blocking the action of vasopressin at the V1A receptor, thereby promoting the excretion of free water and correcting hyponatremia.

See Also[edit | edit source]

References[edit | edit source]



Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD